|
1
|
Adamowicz K and Zaucha R: Evaluation of
the impact of cancer treatment on the adoption and consolidation of
pro-health attitudes in the field of cancer in treated patients
with colon cancer. J Cancer Educ. 2016.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kotelevets L, Chastre E, Desmaële D and
Couvreur P: Nanotechnologies for the treatment of colon cancer:
From old drugs to new hope. Int J Pharm. 514:24–40. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al: Japanese Society for Cancer of the Colon and Rectum (JSCCR)
guidelines 2010 for the treatment of colorectal cancer. Int J Clin
Oncol. 17:1–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Gene. 11:597–610. 2010.
|
|
5
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Flynt AS and Lai EC: Biological principles
of microRNA-mediated regulation: Shared themes amid diversity. Nat
Rev Genet. 9:831–842. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Liu CG, Sevignani C, Ferracin M,
Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kastl L, Brown I and Schofield AC:
miRNA-34a is associated with docetaxel resistance in human breast
cancer cells. Breast Cancer Res Treat. 131:445–454. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rathod SS, Rani SB, Khan M, Muzumdar D and
Shiras A: Tumor suppressive miRNA-34a suppresses cell proliferation
and tumor growth of glioma stem cells by targeting Akt and Wnt
signaling pathways. FEBS Open Bio. 4:485–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodriguez-Ubreva J, Ciudad L, van Oevelen
C, Parra M and Graf T: C/EBPa-mediated activation of microRNAs 34a
and 223 inhibits Lef1 expression to achieve efficient reprogramming
into macrophages. Mol Cell Biol. 34:1145–1157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yothers G, O'Connell MJ, Allegra CJ,
Kuebler JP, Colangelo LH, Petrelli NJ and Wolmark N: Oxaliplatin as
adjuvant therapy for colon cancer: Updated results of NSABP C-07
trial, including survival and subset analyses. J Clin Oncol.
29:3768–3774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Plönes T, Elze M, Kayser G, Pfeifer D,
Burger M and Zissel G: mRNA and miRNA analyses in cytologically
positive endobronchial ultrasound-guided transbronchial needle
aspiration: Implications for molecular staging in lung cancer
patients. Cancer Cytopathol. 122:292–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alexandrov PN, Zhao Y, Jones BM,
Bhattacharjee S and Lukiw WJ: Expression of the
phagocytosis-essential protein TREM2 is down-regulated by an
aluminum-induced miRNA-34a in a murine microglial cell line. J
Inorg Biochem. 128:267–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Castro RE, Ferreira DM, Afonso MB,
Borralho PM, Machado MV, Cortez-Pinto H and Rodrigues CM:
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat
liver and activated by disease severity in human non-alcoholic
fatty liver disease. J Hepatol. 58:119–125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Zou F, Zhang X, Li H, Dulak A,
Tomko RJ Jr, Lazo JS, Wang Z, Zhang L and Yu J: microRNA-21
negatively regulates Cdc25A and cell cycle progression in colon
cancer cells. Cancer Res. 69:8157–8165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun R, Chen P, Li L, Sun H, Nie X, Liang
Y, Yuan F, Pu Y, Bai P, Zhang L and Gao L: A polymorphism rs4705341
in the flanking region of miR-143/145 predicts risk and prognosis
of colorectal cancer. Oncotarget. 2016.(Epub ahead of print).
|
|
20
|
Wei YS, Xiang Y, Liao PH, Wang JL and Peng
YF: An rs4705342 T>C polymorphism in the promoter of miR-143/145
is associated with a decreased risk of ischemic stroke. Sci Rep.
6:346202016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y and
Zheng X: miR-34a inhibits migration and invasion by down-regulation
of c-Met expression in human hepatocellular carcinoma cells. Cancer
Lett. 275:44–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gallardo E, Navarro A, Viñolas N, Marrades
RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez
J and Monzo M: miR-34a as a prognostic marker of relapse in
surgically resected non-small-cell lung cancer. Carcinogenesis.
30:1903–1909. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
